VGNX -- Variagenics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VGNX -- Variagenics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (153)	5/2/2002 9:13:11 PM
From: scaram(o)uche	Read Replies (1) of 269

pointer from the Yahoo thread, eleven84....... fda.gov Keynote address: "Shotguns to Rifles: Pharmacogenetics in Drug Discovery and Treatment" Dr. Jeffrey M. Drazen Editor-in-Chief, NEJM Professor of Medicine, Harvard Medical School Goals of Workshop (snip) 3. Direction: to develop a platform for encouraging the application of pharmacogenetic/pharmacogenomic information to drug development and regulatory review: "where are we now, where do we want to go, and how do we get there?" 4. Guidance: to gather input on how the Agency could best help or promote Pharmacogenetic/Pharmacogenomic science and technology and its use in genetic/genomic-based drug applications, e.g. to develop a guidance.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next